Mazen Hassanain
Overview
Explore the profile of Mazen Hassanain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alolyan A, Alshammari K, Arabi M, Alshehri A, Alsuhaibani H, Ibnshamsah F, et al.
J Hepatocell Carcinoma
. 2024 Feb;
11:349-362.
PMID: 38385059
Hepatocellular carcinoma (HCC) is the sixth most common type of cancer in the world associated with high morbidity and mortality. Despite being a significant healthcare burden there is limited information...
2.
Alfaleh M, Alsulaiman R, Almahboub S, Nezamuldeen L, Zawawi A, Aljehani N, et al.
Antib Ther
. 2024 Feb;
7(1):53-66.
PMID: 38371953
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the Middle East respiratory syndrome coronavirus (MERS-CoV) are highly pathogenic human coronaviruses (CoVs). Anti-CoVs mAbs and vaccines may be effective, but the...
3.
Shoham S, Batista C, Ben Amor Y, Ergonul O, Hassanain M, Hotez P, et al.
EClinicalMedicine
. 2023 Apr;
59:101965.
PMID: 37070102
The COVID-19 pandemic has disproportionately impacted immunocompromised patients. This diverse group is at increased risk for impaired vaccine responses, progression to severe disease, prolonged hospitalizations and deaths. At particular risk...
4.
Al-Otaiby M, Krissaane I, Al Seraihi A, Alshenaifi J, Qahtani M, Aljeri T, et al.
Int J Infect Dis
. 2022 Jul;
122:758-766.
PMID: 35840098
Background: The characterization of reinfection with SARS-CoV-2 has been a subject of concern and controversy, especially with the surge of infections with highly transmissible variants worldwide. Methods: This retrospective national...
5.
Batista C, Hotez P, Ben Amor Y, Kim J, Kaslow D, Lall B, et al.
EClinicalMedicine
. 2021 Dec;
43:101230.
PMID: 34927038
No abstract available.
6.
Alamri S, Alluhaybi K, Alhabbab R, Basabrain M, Algaissi A, Almahboub S, et al.
Front Microbiol
. 2021 Sep;
12:727455.
PMID: 34557174
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) calls for an urgent development of effective and safe prophylactic and therapeutic measures. The spike (S) glycoprotein of severe acute respiratory...
7.
Figueroa J, Hotez P, Batista C, Ben Amor Y, Ergonul O, Gilbert S, et al.
PLoS Med
. 2021 Sep;
18(9):e1003772.
PMID: 34516558
Peter Figueroa and co-authors advocate for equity in the worldwide provision of COVID-19 vaccines.
8.
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
Alluhaybi K, Alharbi R, Alhabbab R, Aljehani N, Alamri S, Basabrain M, et al.
Vaccines (Basel)
. 2021 Aug;
9(8).
PMID: 34451977
The urgent need for effective, safe and equitably accessible vaccines to tackle the ongoing spread of COVID-19 led researchers to generate vaccine candidates targeting varieties of immunogens of SARS-CoV-2. Because...
9.
Hotez P, Batista C, Ben Amor Y, Ergonul O, Figueroa J, Gilbert S, et al.
EClinicalMedicine
. 2021 Aug;
39:101053.
PMID: 34368661
A Lancet Commission for COVID-19 task force is shaping recommendations to achieve vaccine and therapeutics access, justice, and equity. This includes ensuring harmonized through robust systems of global pharmacovigilance and...
10.
Naniche D, Hotez P, Bottazzi M, Ergonul O, Figueroa J, Gilbert S, et al.
EClinicalMedicine
. 2021 Jun;
36:100925.
PMID: 34099998
No abstract available.